Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Predicting conversion from mild cognitive impairment to Alzheimer's disease using neuropsychological tests and multivariate methods.

Chapman RM, Mapstone M, McCrary JW, Gardner MN, Porsteinsson A, Sandoval TC, Guillily MD, Degrush E, Reilly LA.

J Clin Exp Neuropsychol. 2011 Feb;33(2):187-99. doi: 10.1080/13803395.2010.499356. Epub 2010 Aug 13.

2.

Gender-specificities in Alzheimer's disease and mild cognitive impairment.

Beinhoff U, Tumani H, Brettschneider J, Bittner D, Riepe MW.

J Neurol. 2008 Jan;255(1):117-22. doi: 10.1007/s00415-008-0726-9. Epub 2008 Jan 18.

PMID:
18202815
3.

Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment.

Tabert MH, Manly JJ, Liu X, Pelton GH, Rosenblum S, Jacobs M, Zamora D, Goodkind M, Bell K, Stern Y, Devanand DP.

Arch Gen Psychiatry. 2006 Aug;63(8):916-24.

PMID:
16894068
4.

Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative.

Gomar JJ, Bobes-Bascaran MT, Conejero-Goldberg C, Davies P, Goldberg TE; Alzheimer's Disease Neuroimaging Initiative.

Arch Gen Psychiatry. 2011 Sep;68(9):961-9. doi: 10.1001/archgenpsychiatry.2011.96.

PMID:
21893661
5.

Brain ERP components predict which individuals progress to Alzheimer's disease and which do not.

Chapman RM, McCrary JW, Gardner MN, Sandoval TC, Guillily MD, Reilly LA, DeGrush E.

Neurobiol Aging. 2011 Oct;32(10):1742-55. doi: 10.1016/j.neurobiolaging.2009.11.010. Epub 2009 Dec 14.

6.

[Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].

Robert PH, Schuck S, Dubois B, Lépine JP, Gallarda T, Olié JP, Goni S, Troy S.

Encephale. 2003 May-Jun;29(3 Pt 1):266-72. French.

PMID:
12876552
7.

Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease.

Devanand DP, Liu X, Tabert MH, Pradhaban G, Cuasay K, Bell K, de Leon MJ, Doty RL, Stern Y, Pelton GH.

Biol Psychiatry. 2008 Nov 15;64(10):871-9. doi: 10.1016/j.biopsych.2008.06.020. Epub 2008 Aug 23.

8.

Montreal Cognitive Assessment Memory Index Score (MoCA-MIS) as a predictor of conversion from mild cognitive impairment to Alzheimer's disease.

Julayanont P, Brousseau M, Chertkow H, Phillips N, Nasreddine ZS.

J Am Geriatr Soc. 2014 Apr;62(4):679-84. doi: 10.1111/jgs.12742. Epub 2014 Mar 17.

PMID:
24635004
9.

Impact of white matter lesions and cognitive deficits on conversion from mild cognitive impairment to Alzheimer's disease.

Defrancesco M, Marksteiner J, Deisenhammer E, Kemmler G, Djurdjevic T, Schocke M.

J Alzheimers Dis. 2013;34(3):665-72. doi: 10.3233/JAD-122095.

PMID:
23254639
10.

Serial position effects are sensitive predictors of conversion from MCI to Alzheimer's disease dementia.

Egli SC, Beck IR, Berres M, Foldi NS, Monsch AU, Sollberger M.

Alzheimers Dement. 2014 Oct;10(5 Suppl):S420-4. doi: 10.1016/j.jalz.2013.09.012. Epub 2014 Jan 10.

PMID:
24418056
11.

Validity of the Mindstreams computerized cognitive battery for mild cognitive impairment.

Dwolatzky T, Whitehead V, Doniger GM, Simon ES, Schweiger A, Jaffe D, Chertkow H.

J Mol Neurosci. 2004;24(1):33-44. Erratum in: J Mol Neurosci. 2008 Jun;35(2):251.

PMID:
15314247
12.

Differential memory test sensitivity for diagnosing amnestic mild cognitive impairment and predicting conversion to Alzheimer's disease.

Rabin LA, Paré N, Saykin AJ, Brown MJ, Wishart HA, Flashman LA, Santulli RB.

Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2009 May;16(3):357-76. doi: 10.1080/13825580902825220. Epub 2009 Apr 7.

13.

Neuropsychological markers of progression from mild cognitive impairment to Alzheimer's disease.

Marcos A, Gil P, Barabash A, Rodriguez R, Encinas M, Fernández C, Cabranes JA.

Am J Alzheimers Dis Other Demen. 2006 Jun-Jul;21(3):189-96.

PMID:
16869340
14.

Varying strength of cognitive markers and biomarkers to predict conversion and cognitive decline in an early-stage-enriched mild cognitive impairment sample.

Egli SC, Hirni DI, Taylor KI, Berres M, Regeniter A, Gass A, Monsch AU, Sollberger M.

J Alzheimers Dis. 2015;44(2):625-33. doi: 10.3233/JAD-141716.

PMID:
25322924
15.

Predictors of cognitive decline in Alzheimer's disease and mild cognitive impairment using the CAMCOG: a five-year follow-up.

Conde-Sala JL, Garre-Olmo J, Vilalta-Franch J, Llinàs-Reglà J, Turró-Garriga O, Lozano-Gallego M, Hernández-Ferrándiz M, Pericot-Nierga I, López-Pousa S.

Int Psychogeriatr. 2012 Jun;24(6):948-58. doi: 10.1017/S1041610211002158. Epub 2012 Jan 26.

PMID:
22278151
16.

Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: A 5-year follow-up study.

Yoon JH, Kim M, Moon SY, Yong SW, Hong JM.

J Neurol Sci. 2015 Aug 15;355(1-2):174-9. doi: 10.1016/j.jns.2015.06.013. Epub 2015 Jun 10.

PMID:
26076880
17.

Lexical semantic memory in amnestic mild cognitive impairment and mild Alzheimer's disease.

Balthazar ML, Martinelli JE, Cendes F, Damasceno BP.

Arq Neuropsiquiatr. 2007 Sep;65(3A):619-22.

18.

Neuropsychological measures predict decline to Alzheimer's dementia from mild cognitive impairment.

Summers MJ, Saunders NL.

Neuropsychology. 2012 Jul;26(4):498-508. doi: 10.1037/a0028576. Epub 2012 May 21.

PMID:
22612573
19.

Association between fully automated MRI-based volumetry of different brain regions and neuropsychological test performance in patients with amnestic mild cognitive impairment and Alzheimer's disease.

Arlt S, Buchert R, Spies L, Eichenlaub M, Lehmbeck JT, Jahn H.

Eur Arch Psychiatry Clin Neurosci. 2013 Jun;263(4):335-44. doi: 10.1007/s00406-012-0350-7. Epub 2012 Sep 1.

PMID:
22940716
20.

Searching for Primary Predictors of Conversion from Mild Cognitive Impairment to Alzheimer's Disease: A Multivariate Follow-Up Study.

López ME, Turrero A, Cuesta P, López-Sanz D, Bruña R, Marcos A, Gil P, Yus M, Barabash A, Cabranes JA, Maestú F, Fernández A.

J Alzheimers Dis. 2016 Mar 5;52(1):133-43. doi: 10.3233/JAD-151034.

PMID:
27060953

Supplemental Content

Support Center